For the quarter ending 2026-03-31, BRGX had -$23,577 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -26,415 | -1,017,805 | -80,565 | -445,199 |
| Depreciation and amortization | 12,943 | 12,945 | 12,376 | 49,754 |
| Amortization of debt discounts | 0 | 0 | 1,976 | 319 |
| Fair value of common shares issued to officers and directors for services | 6,782 | 0 | 0 | 0 |
| Impairment | - | 725,000 | - | - |
| Fair value of common shares issued for services | 23,571 | 126,712 | 80,915 | 173,106 |
| Fair value of common shares issued as loan incentives | 0 | 975 | 0 | 5,900 |
| Interest capitalized to debt balance | 3,944 | 4,035 | 4,033 | 6,759 |
| Fair value of warrants issued for refunds | - | 0 | 0 | - |
| Write-off of accrued liabilities | 81,334 | - | - | - |
| Accounts receivable | -21,335 | -22,892 | 41,495 | 6,123 |
| Inventories | -14,125 | -2,447 | -24,852 | 23,136 |
| Prepaid expenses and other assets | 914 | -18,986 | 6,446 | -75,533 |
| Accounts payable | 82,984 | 156,339 | -109,148 | 141,321 |
| Accounts payable - related parties | -98,499 | -38,025 | 61,399 | 110,585 |
| Accrued expenses and other liabilities | 33,718 | 53,771 | -24,896 | -47,465 |
| Accrued interest - related parties | 38,088 | 36,911 | 34,835 | 71,399 |
| Deferred revenue | -3,699 | -35,547 | -29,400 | -71,853 |
| Net cash provided by operating activities | 26,629 | 69,636 | -71,564 | 40,900 |
| Purchases of property and equipment | - | 3,057 | 6,000 | 0 |
| Purchases of intangibles | - | 0 | 0 | 50,000 |
| Cash acquired in docsun transaction | - | 0 | 0 | 0 |
| Net cash used in investing activities | - | -3,057 | -6,000 | -50,000 |
| Note and loan payments | 56,017 | 44,142 | 46,674 | 23,592 |
| Increase in note and loan balances - related parties | - | 0 | 0 | 0 |
| Increase in note and loan balances | 5,811 | -1 | 117,507 | 30,000 |
| Net cash used in financing activities | -50,206 | -44,143 | 70,833 | 6,408 |
| Net effect of exchange rate fluctuations | 0 | 0 | 7,222 | -9,256 |
| Net increase/(decrease) in cash and cash equivalents | -23,577 | 22,436 | 491 | -11,948 |
| Cash and cash equivalents, beginning balance | 69,383 | 58,404 | 58,404 | - |
| Cash and cash equivalents, ending balance | 45,806 | 22,436 | 46,947 | - |
BIOREGENX, INC. (BRGX)
BIOREGENX, INC. (BRGX)